Skip to content

Clinical trials

Recruiting Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Status: Recruiting Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20183
20201
20212
20221
20233
20246
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic3
National Cancer Institute (NCI)3
Ohio State University Comprehensive Cancer Center2
Thomas Jefferson University2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1
Branch Office of "Hadassah Medical Ltd"1
Brigham and Women's Hospital1
Memorial Sloan Kettering Cancer Center1
PreludeDx1
Providence Health & Services1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ23
Breast Neoplasms13
Carcinoma, Intraductal, Noninfiltrating8
Lymphoma2
Carcinoma in Situ1
Colorectal Neoplasms1
Head and Neck Neoplasms1
Hypertrophy1
Laryngeal Diseases1
Laryngeal Neoplasms1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.